October 17th 2025, 7:00pm
Lenvima and Keytruda with chemo did not help patients with metastatic esophageal squamous cell carcinoma live longer than Keytruda and chemotherapy alone.
October 17th 2025, 6:20pm
Sevabertinib showed high response rates and durable disease control in patients with HER2-mutant NSCLC, with diarrhea as the main manageable side effect.
October 17th 2025, 5:27pm
Home-based supervised physical activity has no major impact on fatigue and quality of life for patients with metastatic cancer receiving oral targeted therapy.
October 17th 2025, 5:07pm
Gleevec remains effective in advanced gastrointestinal stromal tumors, with complete response or full tumor removal doubling median survival.
October 17th 2025, 2:27pm
The addition of Tecentriq to BCG therapy did not significantly improve outcomes for patients with non–muscle-invasive bladder versus BCG alone.
October 30th 2024, 1:00pm
An expert discussed how patients with breast cancer, particularly those with a BRCA mutation, should consider future fertility and breastfeeding when making treatment decisions.
October 28th 2024, 1:00pm
An expert discussed how liquid and tissue biopsies can help monitor treatment and detect potential resistance in patients with non-small cell lung cancer.
October 26th 2024, 2:00pm
Through regular follow-ups and symptom assessments, breast cancer survivors have the access to physical and emotional support they may need.
October 24th 2024, 9:00pm
An expert explained the advantages and disadvantages of radiation as a treatment for patients with renal cell carcinoma, a type of kidney cancer.
October 19th 2024, 2:00pm
An expert discussed how the understanding of resistance mechanisms can help care teams develop a global treatment strategy for EGFR-mutated non-small cell lung cancer.
Moving Forward After Follicular Lymphoma With a New Companion
How Liver Cancer Is Screened and Staged for Patients
I’m Still Here: My Fight Against Colorectal Cancer
When the Fear of Cancer Creeps Back